Collaborate
Work with the lab
The group is new, so a collaboration can shape the programme. Say what you want to learn, and we will see whether the lab's models and methods can help.
Academic collaborators
For groups whose question meets ours.
Where I would like to collaborate
- Human organoid models of neurodevelopment
- Assays for developmental neurotoxicity
- Human-cell models of neuropathologies, in development and beyond
- Single-cell and sequencing methods applied to exposed neural tissue
- Questions that link human-cell data to clinical or regulatory decisions
What I can bring
- Neuronal and organoid culture, including spinal cord organoids and electrophysiology
- Study design with several readouts in the same cells
- Dose choice anchored to measured human exposure
- Protocols and code shared openly
Formats that work
- Joint grant applications
- Co-supervised students and exchange visits
- Shared methods, data and benchmarks
An example that would fit
You have measured a medicine in maternal blood and want to know what that concentration does to developing human neurons. We expose organoids at that concentration, read electrical activity, morphology and gene expression in the same cells, and write it up together.
What to send
One or two paragraphs: your project, why the lab's models fit, and what you would like to happen in the first six months.
Industry and policy partners
For teams that need human-cell evidence.
Questions I can help with
- Which human-cell assays can show an effect on neurodevelopment, and which readouts to pair
- How to read organoid and cell-line results next to clinical exposure data
- Where preclinical evidence stops answering the question a regulator or clinician asks
My years in clinical research and drug safety shape how experiments are designed so the data can inform a decision.
Formats
- Joint research projects
- Advisory input on assay strategy
- Talks and training for internal teams
Grants we can write together
Programmes where your country, your network or a European call pays for the joint work. In most of them you lead and I join as the Norwegian partner, or the other way round.
| Programme | Who pays | Next date | What the joint project looks like |
|---|---|---|---|
| Poland · EEA and Norway GrantsPOLNORIS, applied research and innovation | Polish funder NCBR, with Norway | 17 Dec 2026 | Three-year project, EUR 1–1.75 million. A Polish organisation or company leads and a Norwegian partner joins. The NCBR page has a matchmaking platform. Source → |
| Poland · EEA and Norway GrantsGRIEG-BIS and LANGSPIL, basic research | Polish funder NCN, with Norway | GRIEG-BIS closed 30 Sep 2026; LANGSPIL expected in the fourth quarter of 2026 | Three-year basic-research projects, EUR 0.8–1.5 million, led by a Polish research organisation with a Norwegian partner. Source → |
| Czechia · EEA and Norway GrantsResearch and innovation call | Czech funders, with Norway | First call autumn 2026 at the earliest | EUR 43 million is set aside for joint research with Norwegian partners. Not yet announced. Source → |
| France · PHC AuroraResearcher exchange | Research Council and French ministries | 2027 call closed 23 Sep 2026; next expected Aug–Sep 2027 | A tenured French researcher and I write the project and apply the same day. One year, renewable. Source → |
| EP PerMed · CGT4PM2027Cell and gene therapy for personalised medicine | European partnership; the Research Council funds Norway (tentatively EUR 1.6 million for 4–5 teams) | Pre-proposal 20 Jan 2027, 14:00 CET; full proposal 25 May 2027 (invited only) | Three-year project with at least three independent partners from three participating countries, each funded by its own national funder, and at least one early-career researcher as principal investigator. The project must develop a cell or gene therapy; human organoids are an accepted preclinical model, so a neural-model partner can join. Source → Norway → Partnering platform (free sign-up) → |
| HFSP Research GrantsTeam grant, 2–4 members | Human Frontier Science Program | Letter of intent ~mid to end March 2027 | USD 300 000 to 500 000 a year for three years, by team size. Teams should be international, ideally across continents, and should not have worked together before. Source → |
| Horizon EuropeExposome call, partner role | European Commission | 17 Feb 2027 (call opened 29 Oct 2026) | EUR 45 million topic on environmental health. The topic centres on exposomics and cohorts. I join an existing consortium for the optional mechanistic work: testing in human brain organoids how chemical/pollutants exposures change neurodevelopment or cause neuropathology. I do not coordinate. Source (work programme, topic HORIZON-HLTH-2027-01-ENVHLTH-02) → |
| MSCA Staff ExchangesAcademic plus non-academic partners | European Commission | 15 Apr 2027 | Funds secondments between universities and companies, regulators or 3Rs centres. A cheap way to build a regulatory partnership. Source → |
| EP BrainHealthJoint transnational calls | European partnership; the Research Council funds Norway | No 2027 call announced | The 2026 round gave Norway about EUR 650 000 for roughly two groups. I will tell you if a 2027 call appears; the project would need a named disorder. Source → |
| Nordic EMBL PartnershipJoint PhD or postdoc with a sister node | NCMBM is one of four nodes (Aarhus, Helsinki, Umeå) | Rolling | A group member whose salary is not on my grant. DANDRITE in Aarhus is the closest fit. Source → |
Hosting a sabbatical or research leave
Faculty, clinicians and industry scientists can spend three to twelve months at the bench in Oslo. Your own institution usually keeps paying you. The lab provides the place and the training.
What I offer
- A desk and bench space for the whole stay
- Hands-on training in organoid culture and the readouts you want to take home
- A seminar slot and a place in group meetings
- Authorship, data and materials agreed in writing before you arrive
Where the money comes from
- Your university’s research-leave salary
- Fulbright, for US scholars coming to Norway
- Erasmus+ staff mobility, for European universities
- PHC Aurora, for French laboratories
- A Research Council visiting-researcher grant, if we plan it into my application a year ahead
How to ask
- Tell me the question you want to take home
- Give the months you have in mind and who pays you
- I reply with what is possible, and with a letter if your funder needs one
Sponsor a question
You may have a question about how a medicine, a chemical or a gene changes the developing brain or under neuropathology, and no lab to ask it in. If human cells or mini-brains can address it, the lab can design the study, and someone other than a research council can pay for it.
Give for a named question
A private person, family or company gives money to the University of Oslo for this project or research area. Nothing is owed back except honest reporting. Gifts to research at UiO can qualify for a Norwegian tax deduction when UiO has your national ID or organisation number.
Pay for a defined study
A company, regulator or foundation needs an answer by a date. We agree the design, the deliverable and the timetable in a contract with the university. The results are still published.
Fund it together
A patient organisation, a family foundation or a group of donors each give a share. I write the one-page brief, you decide whether it is worth funding, and the university holds the money.
Give what the lab uses
Reagents, sequencing runs, cloud time, instrument hours, or a donor-named studentship paid through a gift. Useful when the need is a specific item and not a sum.
How a question becomes a project
- Write the questionOne paragraph in your own words. No jargon needed.
- Talk to meA thirty-minute video call. I ask what you would do with the answer.
- Scoping noteTwo pages: can human cell models address it, what it would take, and which ethics approvals apply. No charge.
- Agreement through UiOGift or contract, signed with the university. Work starts when the funds arrive.
Terms I keep
- I design the study. You set the question, I choose the cells, doses and readouts.
- We publish what we find, including a result that says no. UiO declines gifts that restrict publication or academic freedom.
- You receive a plain-language summary at each stage, and the paper when it appears.
- All money goes through the University of Oslo. I never accept funds personally.
- I cannot promise an answer or a therapy, and I cannot give medical advice about any person.
- Human cell work follows Norwegian ethics and biobank rules. Where a project needs approval, it waits for it.
Other ideas I would like to hear about
Arrangements that cost the lab little and teach everyone something.
- A clinician at the bench. A neonatologist, obstetrician or pharmacist spends weeks in the lab on a secondment, paid by the hospital.
- A drug-safety scientist on secondment. A company or contract research organisation sends someone for three to six months.
- Parents and patients in the design. An advisory panel that shapes which exposures and outcomes we study. No money involved.
- Reference chemicals. Companies can supply compounds with known human exposure to test the regulatory in vitro battery.
- Co-supervised student projects with pharmacy, medicine and biomedical programmes elsewhere.
- Prizes and awards. Nominations for animal-free research prizes, where the lab can apply and share the money with a partner.
Why human tissue only?
Our current work uses human cells and tissue. They are the species the clinical question is about, and they let us replace animal experiments where we can. That choice shapes which projects fit.